本文選題：突發(fā)性耳聾　切入點(diǎn)：靜脈　出處：《中國臨床藥理學(xué)與治療學(xué)》2016年11期

【摘要】：目的:探討應(yīng)用甲基強(qiáng)的松龍治療突發(fā)性耳聾的最佳給藥途徑。方法:將突發(fā)性耳聾患者117例分為三組,每組39例。靜脈組給予靜脈注射甲基強(qiáng)的松龍;鼓膜穿刺組給予鼓室內(nèi)注射甲基強(qiáng)的松龍;耳后注射組給予耳后乳突區(qū)骨皮質(zhì)下注射注射甲基強(qiáng)的松龍。結(jié)果:靜脈組顯效率高于鼓膜穿刺組,差異有統(tǒng)計(jì)學(xué)意義(P0.05)。靜脈組總有效率高于鼓膜穿刺組、耳后注射組,差異有統(tǒng)計(jì)學(xué)意義(P0.05)。結(jié)論:靜脈注射甲基強(qiáng)的松龍治療突發(fā)性耳聾療效可靠,總有效率穩(wěn)定,可作為突發(fā)性聾激素治療的給藥方法。
[Abstract]:Objective: to explore the best way to treat sudden deafness with methylprednisolone. Methods: 117 patients with sudden deafness were divided into three groups, 39 cases in each group. Methylprednisolone was injected into the tympanic cavity in the tympanic membrane puncture group, and methylprednisolone was injected into the posterior mastoid area of the ear in the retroauricular injection group. Results: the effective rate of the vein group was higher than that of the tympanic membrane puncture group. The total effective rate of vein group was higher than that of tympanic membrane puncture group and retroauricular injection group (P 0.05). Conclusion: the efficacy of intravenous injection of methylprednisolone in the treatment of sudden deafness is reliable and the total effective rate is stable. It can be used as an administration method for the treatment of sudden deafness hormone.
【作者單位】： 浙江寧波市第一醫(yī)院耳鼻咽喉科頭頸外科;寧波大學(xué)醫(yī)學(xué)院;
【基金】：寧波市科技計(jì)劃項(xiàng)目(2013A610261)
【分類號(hào)】：R764.437

【相似文獻(xiàn)】

相關(guān)期刊論文 前10條

1 朱世保;老藥新用治療突發(fā)性耳聾[J];安徽醫(yī)藥;2001年03期

2 林曉江;突發(fā)性耳聾16例誤診討論[J];醫(yī)學(xué)理論與實(shí)踐;2001年08期

3 吳桂芬,李芳春,邢力萍;杏丁治療突發(fā)性耳聾的臨床體會(huì)[J];現(xiàn)代護(hù)理;2002年04期

4 楊s，

本文編號(hào)：1660710